Letter

Pharmacological heterogeneity limits antidepressant study

BMJ 2003; 327 doi: 10.1136/bmj.327.7409.289-a (Published 31 July 2003)
Cite this as: BMJ 2003;327:289.2

This article has a correction

Please see: Antidepressant prescribing and suicide

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anthony S Hale, professor of psychiatry (A.S.Hale@ukc.ac.uk)
  1. University of Kent, Canterbury CT2 7NZ

    EDITOR—MacGillivray et al potentially make a huge contribution to the understanding of the relative utility of selective serotonin reuptake inhibitors and older antidepressants in the treatment of depression in primary care.1 However, the usefulness of their meta-analysis is limited by the original data, as is so often the case.

    These results …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular